PAMELA FOUNTAIN: Open Payments
NPI 1194955757 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 50 payments from 7 companies in 2025. Trend: 2023 $661 · 2024 $458 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $352 |
| E.R. Squibb & Sons, L.L.C. | 25 | $324 |
| Otsuka America Pharmaceutical, Inc. | 2 | $249 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $130 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Alkermes, Inc. | 1 | $20 |
Products named: AUSTEDO XR, REXULTI, COBENFY, INGREZZA, UZEDY, CAPLYTA, LYBALVI.
Industry payments across IN — which companies pay providers there.
